Thomas Ritter
- Genetics top 0.2%
- Mesenchymal stem cell research 34
- Virus-based gene therapy research 29
- Immunology top 1%
- T-cell and B-cell Immunology 22
- Immunotherapy and Immune Responses 19
- Rehabilitation top 1%
- Transplantation top 2%
- Cancer Research top 2%
-
- Corneal Surgery and Treatments 29
- Corneal surgery and disorders 12
-
- RNA Interference and Gene Delivery 20
- Extracellular vesicles in disease 18
- Co-authors
- Matthew D. GriffinAideen E. RyanSweta RaniHans‐Dieter VolkOliver TreacyPaul LohanRhodri CeredigMichelle M. Duffy
- Cited by
- GeneticsImmunologyRehabilitation
- Journals
- Stem Cell Research & Therapy (7 papers)The Journal of Immunology (5 papers)Human Gene Therapy (5 papers)
- Partner nations
- IrelandGermanyUnited States
In The Last Decade
Thomas Ritter
139 papers receiving 7.1k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Genetics 1.9k
- Immunology 1.8k
- Rehabilitation 384
- Transplantation 139
- Cancer Research 740
Countries citing papers authored by Thomas Ritter
This map shows the geographic impact of Thomas Ritter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Ritter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Ritter more than expected).
Fields of papers citing papers by Thomas Ritter
This network shows the impact of papers produced by Thomas Ritter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Ritter. The network helps show where Thomas Ritter may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Ritter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 5 | |
| 3 | 2024 | 0 | |
| 4 | 2023 | 13 | |
| 5 | 2023 | 10 | |
| 6 | 2018 | 68 | |
| 7 | 2017 | 33 | |
| 8 | 2014 | 60 | |
| 9 | 2009 | 17 | |
| 10 | 2009 | 9 | |
| 11 | 2008 | 43 | |
| 12 | 2007 | 6 | |
| 13 | 2005 | 458 | |
| 14 | 2005 | 4 | |
| 15 | 2004 | 6 | |
| 16 | 2002 | 77 | |
| 17 | 2001 | 11 | |
| 18 | 2000 | 47 | |
| 19 | 2000 | 13 | |
| 20 | 1999 | 3 |
About Thomas Ritter
Thomas Ritter is a scholar working on Genetics, Immunology, Radiology, Nuclear Medicine and Imaging, Genetics and Molecular Biology, having authored 141 papers that have together received 7.2k indexed citations. Recurring topics across this work include Mesenchymal stem cell research (34 papers), Virus-based gene therapy research (29 papers), Corneal Surgery and Treatments (29 papers), T-cell and B-cell Immunology (22 papers), RNA Interference and Gene Delivery (20 papers), Immunotherapy and Immune Responses (19 papers), Extracellular vesicles in disease (18 papers) and Corneal surgery and disorders (12 papers). The work is most often cited by research in Genetics (1.9k citations), Immunology (1.8k citations), Rehabilitation (384 citations), Transplantation (139 citations) and Cancer Research (740 citations). Thomas Ritter has collaborated with scholars based in Ireland, Germany and United States. Frequent co-authors include Matthew D. Griffin, Aideen E. Ryan, Sweta Rani, Hans‐Dieter Volk, Oliver Treacy, Paul Lohan, Rhodri Ceredig, Michelle M. Duffy, Mary Murphy and Bernard P. Mahon. Their work appears in journals such as Stem Cell Research & Therapy, The Journal of Immunology, Human Gene Therapy, Transplantation and Journal of Cellular and Molecular Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.